CV/COS Webinar: Clip 9

In the world of cancer care, different disease stages present unique challenges and experiences for patients. At Carevive, we recognize the importance of considering the stage of disease when analyzing the impact and quantification of tolerability, physical function, and symptoms. Early-stage disease patients may not be symptomatic, and treatment administration may have minimal interference as they work towards remission or cure. Real-world data collection allows us to gain valuable insights into the varying needs and experiences of patients at different stages, enabling us to tailor care strategies to meet their specific requirements and improve overall outcomes.

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…